Pfizer vaccine efficacy
Arbutus files patent infringement lawsuit against Pfizer/BioNTech over COVID shots
The lawsuit by Arbutus and Genevant says Pfizer/BioNTech engaged in licensing discussions for the technology but they did not "result in a settlement."
mRNA could make flu vaccines more effective - here's how
US CDC still looking at potential stroke risk from Pfizer bivalent COVID shot
COVID increases risk of maternal death - study
If COVID boosters are so effective, why isn’t everyone getting one?
Hebrew University epidemiologist and public health physician Prof. Hagai Levine said that there is not necessarily proof that a third shot is needed for everyone.
For Pfizer COVID-19 vaccine in children benefits outweigh risks - FDA
If the FDA authorizes the Pfizer/BioNTech immunization for children 5 to 11 years old, it would be the first COVID-19 vaccine for the age group.
FDA to allow mix and match of COVID-19 booster vaccines- NYT
The government would not recommend one shot over another, and it might note that using the same vaccine as a booster when possible is preferable, the NYT report said.
If the chickenpox vaccine lasts 20 years, why not the COVID-19 shot?
Will the third booster shot be our last? Israeli doctors explain the science behind it.
Pfizer/BioNTech COVID-19 vaccine effectiveness drops after 6 months -study
The analysis showed that the vaccine's effectiveness in preventing hospitalization and death remained high at 90% for at least six months.
Pfizer COVID vaccine finally wins full FDA approval
The vaccine will now be officially marketed under the name Comirnaty * Pfizer shares were up around 5% and BioNTech shares were up more than 9%.
US to begin COVID-19 vaccine booster shots in September
COVID-19 vaccine booster shots will be made widely available to Americans starting on September 20, pending FDA approval and CDC recommendation.
British study shows COVID-19 vaccine efficacy wanes under Delta
A British study found that protection from either of the two most commonly used COVID-19 vaccines against the Delta variant weakens within three months.
Up to 43% increase in developing COVID antibodies after third dose - study
A study released Friday found that immunosuppressed individuals developed 43% more antibodies from the third vaccine than they did from the second, suggesting that the third jab is highly effective
COVID: 88% of people who receive 3rd shot feel similar or better than 2nd
Some 14 people out of more than 400,000 who were vaccinated with a third shot were diagnosed with the virus, among them two who were hospitalized.
